New Filings

Valeo Inc. filed IPR2014-01203 challenging U.S. Patent No. 7,859,565 assigned to Donnelly Corporation.

Institution Decisions

In Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc., IPR2014-00360 Paper 16 (July 25, 2014), the Board instituted Inter Partes review as to claims 1, 2, 6, 12-14, 17, 21-43, 45-51, and 54-71 of U.S. Patent No. 8,329,216, but not as to challenged claims 72-82.

In Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc., IPR2014-00361 Paper 14 (July 25, 2014), the Board denied Inter Partes review of U.S. Patent No. 8,309,122 as barred by 35 U.S.C. 315(b).

In Coupa Software, Inc. v. Ariba, Inc., CBM2-14-00061, Paper 11 (July 25, 2014), the Board instituted a cover business method review of claims 1-45 of U.S. Patent No. 7,117,165.

In Finjan, Inc. v. FireEye, Inc., IPR2014-00492, Paper 8 (July 25, 2014), the Board instituted inter partes review of claims 1, 3–8, 12–14, 16–20, and 22–30 of U.S. Patent No. 8,171,553, but not as to challenged claims 2, 9-11, 15, and 21.

Final Written Decision

In Intelligent Bio-Systems, Inc. v. Illumina Cambridge Limited, IPR2013-00128, Paper 92 (July 25, 2014), the Board granted patent owner motion to cancel claims 1 through 8 of U.S. Patent No. 7,057,026, effectively ending the inter partes review, since the Board denied patent owner’s motion to add claims 9 through 12.